Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cells
- Resource Type
- article
- Source
- Nature Communications, Vol 12, Iss 1, Pp 1-14 (2021)
- Subject
Science - Language
- English
- ISSN
- 2041-1723